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Sodium, renin, aldosterone, catecholamines, and blood pressure
in diabetes mellitus. Interrelations among plasma renin activity
(PRA), aldosterone and cortisol levels, blood volume, exchangea-
ble sodium, urinary catecholamines, and blood pressure were
studied in 35 normal subjects and 60 age-matched non-azotemic
patients with diabetes mellitus (60% with hypertension, 15% with
orthostatic hypotension). Basal PRA, plasma aldosterone, corti-
sol, blood volume, plasma potassium, and urinary electrolytes
were comparable in diabetic and normal subjects. Diabetic
patients, however, had a 10% increase in body sodium (P <0.01),
and 8% of them showed normal postural PRA responses and
subnormal aldosterone responses; 22% had subnormal PRA and
normal aldosterone responses, and 17% had subnormal responses
of PRA and aldosterone. Non-PRA-related aldosterone responses
could not be explained by ACTH or electrolytes. Orthostatic
decreases in blood pressure correlated (P < 0.01) with both
catecholamine excretion and basal PRA. This suggests that in
diabetes mellitus, body sodium is increased. Basal PRA and plas-
ma aldosterone are usually normal, but their postural responses
are frequently impaired. Absent aldosterone responses, despite
normal PRA responsiveness, may reflect an adrenal abnormality
or an ineffective form of renin. Marked postural aldosterone stimu-
lation, unrelated to PRA, ACTH, or electrolytes, points to a potent
unknown factor in aldosterone control. Low levels of free periph-
eral catecholamines and PRA may be complementary factors con-
tributing to postural hypotension.
Sodium, rénine, aldostérone, catécholamines et pression artér-
ielle dans le diabète sucré. Les inter-relations entre l'activité rénine
plasmatique (PRA), les concentrations d'aldostérone et de corti-
sol, le volume sanguin, le sodium echangeable, les catécholamines
urinaires et Ia pression artérielle ont été étudiées chez 35 sujets
normaux et 60 malades atteints de diabète, sans insufilsance rénale
et dont les ages étaient appariés (60% avaient une hypertension et
15% une hypotension orthostatique). La PRA de base,
l'aldostérone et le cortisol plasmatiques, le volume sanguin, le
potassium plasmatique et les electrolytes urinaires étaient compa-
rabIes chez les diabétiques et les sujets normaux. Les malades
diabétiques, cependant, ont une augmentation de 10% de leur
sodium corporel (P < 0,01). Huit pour cent d'entre eux ont une
réponse posturale de PRA normale et une réponse de l'aldostérone
inférieure a Ia normale, 22% ont une reponse de PRA inférieure a
Ia normale et une reponse de l'aldosterone normale, et 17% ont
des réponses de PRA et de l'aldostérone inferieures a Ia normale.
Les réponses de l'aldostérone sans rapport avec PRA ne peuvent
pas être expliquées par I'ACTH ou les electrolytes. Les diminu-
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tions de Ia pression artérielle liées a l'orthostatisme sont correlées
(P < 0,01) a Ia fois avec l'excrétion de catécholamines et Ia PRA
de base. Ceci suggère qu'au cours du diabète le sodium corporel
est augmenté. La PRA et l'aldostérone de base sont souvent
normales mais leur réponse posturale est souvent modifiée.
L'absence de réponse de l'aldostérone malgré une réponse nor-
male de PRA peut traduire une anomalie surrénale ou une forme
de rénine inefficace. Une stimulation posturale importante de
l'aldostérone non expliquée par Ia PRA, I'ACTH ou les électro-
lytes oriente vers un facteur inconnu mais puissant du contrôle de
Ia sécrétion d'aldostérone. Des concentrations basses de catéchol-
amines libres et une PRA basse peuvent être des facteurs complé-
mentaires qui participent a l'hypotension posturale.
Diabetes mellitus is frequently accompanied by
hypertension [1] and may be associated with ortho-
static hypotension [2]. Relatively little, however, is
known about major blood pressure-regulating factors
such as the catecholamines, the renin-angiotensin-
aldosterone system, and the body sodium-volume
state in patients with diabetes mellitus. Plasma levels
of total catecholamines were studied in a group of
long-term diabetics with normal or elevated blood
pressure and were found to be reduced in patients
with neuropathy and normal in those without neu-
ropathy [31. Regarding renin-aldosterone activity,
we previously noted an association between diabetes
mellitus and the syndrome of hyporeninemic hypoal-
dosteronism [4, 5]. Moreover, some recent studies
have suggested that plasma renin activity is normal
in uncomplicated diabetes mellitus, but may be low
in diabetic patients with nephropathy, orthostatic
hypotension, or hypertension [1, 6-8].
Theoretically, changes in plasma renin or aldoste-
rone levels occurring in a diabetic patient could be
related directly to an aspect of the underlying meta-
bolic disorder; or they could develop as a conse-
quence of associated alterations in the body sodium-
volume state [9], the function of the sympathetic
system [10], the activity of the pituitary-adrenal axis
[11], the blood pressure [12, 13], or renal structural
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changes [5, 6, 14]. Furthermore, disturbances in the
balance between the three former factors could lead
to abnormalities in blood pressure regulation. There-
fore, the present study was undertaken to systemati-
cally analyze the interrelations among plasma refill,
aldosterone and cortisol levels, blood volume and
exchangeable body sodium, urinary catecholamine
excretion rates and blood pressure in a large popula-
tion of patients with clinically stable diabetes melli-
tus. Possible alterations in these components were
delineated by comparing the diabetic patients, all of
whom were non-azotemic, with age-matched normal
control subjects.
Methods
Sixty patients with diabetes mellitus and 35 age-
matched normal volunteers were studied. They were
stratified into three age-groups, and diabetic and nor-
mal subjects were age-matched. The young groups
(25 to 39 yr) included 10 diabetic patients (6 males
and 4 females) and 10 normal subjects (6 males and 4
females). The middle-aged groups (40 to 59 yr) con-
sisted of 22 patients (10 males and 12 females) and 11
normal subjects (5 males and 6 females). The elderly
groups (60 to 70 yr) comprised 28 diabetic patients
(12 males and 16 females) and 14 normal subjects (5
males and 9 females).
The diagnosis of diabetes mellitus was established
by standard laboratory methods. All patients were
followed regularly in the Diabetes Clinic at the Medi-
cal Policlinic, University of Berne, and all were stud-
ied, similarly to the control subjects, in the same
institution. None of the patients showed clinical r
laboratory evidence of congestive heart failure, ede-
ma, or renal failure, and their metabolic state was
good or fairly well controlled at the time of the study.
The control subjects were healthy persons with a
blood pressure of 140/90 mm Hg and without signs
of heart or kidney disease or other disorders.
Antihypertensive drugs and diuretics were discon-
tinued at least 14 days before the study; the dose of
insulin or hypoglycemic drugs, and carbohydrate
intake were not altered. Patients were instructed not
to add salt to their food, starting at least five days
prior to the test.
Following the oral administration of approximate-
ly 60 Ci of radioactive sodium (24Na) between 8:00
and 8:30 A.M., a 24-hr urine was collected for the
determination of 23Na, 24Na, potassium, creatinine,
and catecholamine excretion rates. During the last
hour of the 24-hr period, the subjects remained
recumbent; at the end of this equilibration period,
blood pressure and pulse rate were determined, and
venous blood samples were collected from an
indwelling cannula for determination of plasma 23Na,
24Na, potassium, and creatinine concentrations,
blood glucose level, and plasma renin activity (PRA),
aldosterone and cortisol concentrations. Immediate-
ly thereafter, plasma volume was determined in the
supine position, using a contralateral vein for the
injection of 20 j.Ci of human serum albumin radioac-
tively labeled with iodine-131 (1311-HSA). Subjects
then changed from the supine to upright posture, and
measurements of blood pressure, pulse rate, and
plasma sodium, potassium, PRA and plasma aldoste-
rone and cortisol levels were repeated following one
hour of ambulation.
Blood pressure was measured using standard pres-
sure cuff and sphygmomanometer. The pressure at
the disappearance of the Korotkoff sounds was con-
sidered as the diastolic pressure. Each blood pres-
sure reading was the mean of three recordings. The
mean pressure was calculated as the sum of the
diastolic and one-third of the pulse pressure.
Plasma and urinary sodium and potassium concen-
trations were determined by a flame photometer
(Instrumentation Laboratory). Exchangeable body
sodium and plasma volume were measured by the
isotope dilution technique, using 24Na and '311-HSA,
respectively, and blood volume was calculated based
on the measurement of 131J activity in whole blood
and corrected for large vessel hematocrit; the stan-
dardized techniques in this laboratory have been
described previously [15, 16]. Exchangeable sodium,
and plasma or blood volumes were expressed as
mEq/kg of lean body mass (LBM) and mllkg of
LBM, respectively; LBM was estimated using the
leanness index (body height3/weight) of Nicholson
and Zilva [17]. PRA and plasma aldosterone concen-
tration were measured by radioimmunoassay [18,
19]; plasma cortisol, by competitive protein binding
assay [20]; and urinary catecholamines, by the meth-
od of Bertler, Carlsson, and Rosengren [21]. The
"volume-renin-product" was obtained by multiply-
ing blood volume computed for LBM with the natu-
ral logarithm of PRA (expressed in ng/liter/min) to
avoid negative logarithms; the "sodium-renin-prod-
uct" was derived in a similar way [13, 15]. Blood
glucose was determined by the hexokinase method;
plasma creatinine levels, by a Greiner Analyzer; and
plasma albumin, by the bromocresol green method
[22].
An unpaired data t test was used for data compari-
son between patients and control subjects, or
between age-groups or other subgroups of patients or
controls. A paired data t test was applied for data
comparison between the supine and upright pos-
tures. In our previous studies, absolute plasma renin
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and aldosterone levels and urinary catecholamine
excretion rates were found to be abnormally distrib-
uted, with an approximately normal distribution fol-
lowing logarithmic transformation [13, 15, 16, 231.
Therefore, natural logarithms of these values were
utilized for all statistical calculations involving a t
test or linear regression analysis.
Results
Clinical characteristics of the diabetic study popu-
lation (Table 1). Considering all diabetic patients
together, we found that the mean duration of this
disease was 10.2 yr; 50% of the patients were treated
with insulin; 60% had hypertension (supine blood
pressure,> 140/90 mm Hg; and/or mean pressure,>
107 mm Hg) 15% exhibited persistent (1-hr) ortho-
static decreases in blood pressure exceeding 40 mm
Hg systolic and 20 mm Hg diastolic, andlor 27 mm
Hg mean blood pressure; 42% had retinopathy; 37%
showed neuropathy; and 15% had peripheral occlu-
sive arterial disease. Moreover, 28% of the patients
had nephropathy, as evidenced by proteinuria and/or
a mild reduction in GFR which was measured by the
constant infusion clearance technique using ethylene
diamine tetraacetate labeled with chromium-5 1 [24],
although plasma creatinine concentrations were nor-
mal in all patients studied ( 1.3 mg/lOO nil). Mean
blood glucose concentration, measured approxi-
mately one hour after a light breakfast with minimal
fluid intake (1 cup), was 207 mg/100 ml. Considering
the three age-groups individually, we found that the
known duration of diabetes and the prevalence of
diabetic retinopathy, neuropathy, and occlusive arte-
rial disease were highest in the young patients, while
hypertension was more prevalent in the elderly
patients, and orthostatic hypotension and nephropa-
thy were about equally distributed.
Blood pressure and pulse rate (Fig. 1). The mean
supine blood pressure and pulse rate were signifi-
cantly higher in the middle-aged and elderly patients
with diabetes than in the age-matched control groups
100
::F
Supine Upright
Fig. 1. Blood pressure and pu/se rate in age-matched normal
subjects and diabetic patients. One asterisk (*) depicts a significant
difference between diabetic and normal subjects (P < 0.02); two
asterisks (**) indicate a significant orthostatic change (P <0.025).
The closed circles (.)denote values for normal subjects; the open
circles (0), diabetic patients. All values represent the mean SEM.
Table 1. General characteristics of the diabetic study populations
All patients(N=60)
Age groups
Young(N=10) Middle-aged(N=22) Elderly(N=28)
Age, yr
Duration of diabetes, yr
Blood glucose, mg/I 00 ml
Plasma creatinine, mg/l00 ml
Insulin therapy, %
Prevalence of complications,
Hypertensionc
Orthostatic hypotensiond
Retinopathy
Neuropathy
Nephropathy
Peripheral occlusive
arterial disease
%
54.6 13.1
10.2 8.4
206.8 98.9
0.94 0.30
50
60
15
42
37
28
15
32.0 46b
14.8 9.7
233.4 91.6
0.94 0.24
100
50
20
70
50
33
30
50.8 6.5
10.8 9.0
218.0 101.3
0.83 0.20
55
55
9
50
41
32
14
65.6
8.1 6.8
188.4 99.4
1.03 0.37
29
68
18
25
29
25
11
All values denote the mean SEM.
Values in normal control subjects are: young group, 32.0 4.9 yr; middle-aged group, 48.0 6.6 yr; elderly group, 65.5 3.0 yr.
Supine blood pressure, > 140/90 mm Hg; and/or supine mean blood pressure, > 107 mm Hg.
d Blood pressure fall of> 40mm Hg systolic and > 20mm Hg diastolic and/or> 27mm Hg mean, measured after one hour of ambulation.
o .5
Young:
120100
80
Middle-aged:
120
S
100
80
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C
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(P < 0.05); a similar, although statistically insignifi-
cant, tendency was also noted in the young diabetics.
When measured following one hour of ambulation, a
significant (P < 0.025) orthostatic decrease in mean
blood pressure was observed in the elderly normal
subjects and in the middle-aged and elderly diabetic
patients; thus, mean upright blood pressure was still
higher in the diabetic patients than in the age-
matched control subjects, but this was significant for
the middle-aged groups only (P < 0.05). Pulse rates
showed a postural rise in each study group (P <
0.025), and magnitude of this did not differ signifi-
cantly between the normal and diabetic subjects.
Body fluid-electrolyte status (Table 2). Regardless
of their age, the diabetic patients had a lower mean
concentration of plasma sodium (P < 0.005) and a
higher exchangeable body sodium (P < 0.05) than
normal subjects had. Body sodium was comparable
in patients with or without insulin therapy (48.4 3.5
vs. 50.0 5.5 mEq/kg of LBM). Plasma potassium,
urinary sodium and potassium excretion, plasma and
blood volumes, and hematocrit did not differ signifi-
cantly between the two populations. Except for a
tendency of plasma potassium to increase with aging
in the diabetic patients (P <0.05), there were no age-
related variations in the fluid-electrolyte status of the
patients or normal subjects.
The mean serum albumin concentration was sig-
nificantly lower in the patients with diabetes than
that in the normal subjects (4.19 0.37 vs. 4.35
0.33 g!100 ml; P <0.02).
Plasma renin activity, aldosterone and cortisol
levels, and urinary catecholamines. In both diabetic
patients and normal subjects, PRA decreased with
aging (Table 3). In the diabetic patients, the supine
PRA correlated significantly with the urinary nor-
adrenaline excretion rate (r = 0.28; P < 0.05), but
not with any of the other measured parameters; no
such correlation was found in normal subjects.
Upright PRA did not correlate with other measured
parameters.
In the normal subjects, plasma aldosterone levels
also tended to be lower in the elderly than in the
young age-group; no age-related decrease of plasma
aldosterone levels, however, was noted in the dia-
betic patients (Table 3). Furthermore, except for a
significantly lower mean upright plasma aldosterone
level in the young diabetic patients, as compared to
that in young normal subjects (P < 0.02), mean
supine and upright PRA or plasma aldosterone levels
did not differ significantly between age-matched dia-
betic patients and normal subjects.
Plasma cortisol levels showed no significant age-
dependent variations and were also comparable in
the normal subjects and diabetic patients (Table 3).
While urinary noradrenaline and total catecholamine
excretion rates showed no significant variations with
aging in the diabetic patients, adrenaline excretion
was significantly lower in the elderly than it was in
the young patients (P < 0.05). Urinary catechol-
amines, however, also did not differ significantly
between age-matched normal subjects and diabetic
patients.
Postural responsiveness of plasma renin and a/do-
sterone. When compared with the normal subjects,
the diabetic patients analyzed as one group showed a
significant reduction in mean postural PRA respon-
siveness (P <0.005), while mean increases in plasma
aldosterone were not significantly impaired. In 95%
of a population of 60 normal subjects [16], the PRA
and plasma aldosterone levels obtained in the supine
position were increased by at least 40% after one
Table 2. Plasma and urinary sodium and potassium concentrations, exchangeable body sodium concentrations, plasma and blood volumes,
and hematocrit in patients with diabetes mellitus and age-matched normal subjects'
Urinary
Plasma
sodium
mEqiliter
Plasma
potassium
mEqi/iter
Urinary
sodium
mEq/24 hr
potassium
rnEq/24 hr Hematocrit
hr %
Exchangeable
sodium
mEq/kg LBM'
Plasma
volume
mi/kg LBM'
Blood
volume
mi/kg LBM' Leanness index
Normal subjects
Young (N = 10) 141.4 2.2 3.88 0.18 124 62 72 20 43.6 4.0 44.4 4.1 42.5 6.8 74.7 10.8 0.0823 0.0062
Middle-aged (N II) 140.6 1.3 4.11 0.37 138 46 63 13 43.1 4.4 44.9 4.1 41.6 6.6 73.2 10.7 0.0735 0.0092
Elderly (N = 14) 141.8 1.4 4.07 0.34 125 77 58 18 43.0 3.9 44.4 3.4 42.6 5.0 72.9 9.6 0.0706 0.0122
Diabetes patients
Young (N = 10)
Middle-aged (N = 22)
137.3 2.5'
136.8 2.6'
3.70 0.36
4.04 0.34'
140 37
160 79
62 15
80 32
43.0 3.9
42.3 4.8
48.4 3.3'
48.0 4.l'
40.6 5.8
39.0 9.5
67.7 8.2 0.0791 0.0151
71.3 13.0 0.0604 0.0124
Elderly (N = 28) 138.1 3.0' 4.08 0.32' 149 60 68 21 42.5 3.9 49.5 5.4' 43.2 6.0 77.4 7.4' 0.0620 0.0100
'All values denote the mean SD.
b LBM = lean body mass.
P <0.005 vs. age-matched normal subjects.
P < 0.05 vs. age-matched normal subjects.
P <0.05 vs. young diabetic patients.
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Table 3. Plasma renin activity (PRA), aldosterone and cortisol levels, and urinary catecholamine
diabetes mellitus, stratified by age'
s in normal subjects and in patients with
PRA Aldosterone Cortisol Catecholamines
nglmllhr ngl/OO ml g/IOO ml p.glg of creatinine
Supine Upright Supine Upright Supine Upright Total
position position position position position position Adrenaline Noradrenaline catecholamines
Young
Normal (N = 10) 2.20 1.36 6.29 5.28 7.2 5.5 27.1 16.5 12.1 4.4 10.9 3.6 4.1 2.4 29.2 16.6 33.3 16.2
Diabetes (N = 10) 2.55 1.66 4.11 1.62 6.7 4.0 11.9 ii.5 11.0 4.6 10.8 7.2 4.6 3.6 23.2 15.3 28.1 17.5
Middle-aged
Normal (N = Ii) 1.52 0.80 3.69 2.16 4.5 1.5 13.3 5.9 11.9 4.9 10.0 5.2 4.6 6.1 30.0 15.2 34.5 16.1
Diabetes (N = 22) 1.89 1.24 3.64 2.62 4.5 2.3 16.1 9.0 9.7 3.8 10.3 4.2 2.8 3.3 30.1 17.2 32.9 17.1
Elderly
Normal (N = 14) 1.00 0.47 2.66 l.85e 4.4 1.2 14.7 45c 8.8 3.9 13.5 7.4 2.4 3.1 31.1 13.3 33.6 15.7
Diabetes (N = 28) 1.30 0.91l 2.22 1.79°' 5.3 3.6 12.7 9.5 11.0 5.3 9.1 3.2 2.0 3.l 27.5 18.1 29.5 18.7
Values represent the mean SD.
P <0.02 vs. age-matched normal subjects.
P <0.05 vs. young subjects or patients.
P <0.05 vs. middle-aged diabetes patients.
hour of ambulation. Using this increase as the nor-
mal postural responsiveness, we have found that the
patients with diabetes mellitus show four different
response patterns (Fig. 2). Of the 59 patients in
whom the effects of posture were studied, 31 patients
(53%) exhibited normal renin and aldosterone
responses; in this group of patients, PRA increased
144 (sEM) 16%, and the plasma aldosterone level
rose 319 45%, as compared to 165 20% and 273
34%, respectively, in normal subjects. Five (8%)
of the diabetic patients showed a normal PRA
response and a subnormal aldosterone response (93
34% and —3 13%, respectively). Thirteen
patients (22%) had a subnormal PRA response and a
normal aldosterone response (16 3 and 298
82%). Finally, 10 patients (17%) had subnormal pos-
tural responses of both PRA and plasma aldosterone
levels (7 7 and 5 7%).
Both patient-subgroups with a normal postural
aldosterone response showed a significant orthostat-
ic fall in blood pressure (Fig. 2). In contrast, no
significant orthostatic variations in blood pressure
were noted in the two patient-subgroups with a
blunted aldosterone response or in the normal sub-
jects. Postural changes in mean plasma cortisol were
insignificant in both normal subjects and patient-
subgroups.
When comparing other clinical or laboratory fea-
tures among diabetic renin-responders or aldoste-
rone-responders and non-responders (Table 4), no
significant differences were apparent regarding the
age of the patients, the prevalence of hypertension,
orthostatic hypotension, retinopathy, neuropathy or
nephropathy, the use of insulin or oral antidiabetic
agents, blood glucose concentrations, or exchangea-
ble sodium, blood volume, plasma or urinary electro-
lytes, or catecholamine excretion rates.
Normal
sublects
(N=34)
Patients with diabetes mellitus I
i
'
Responsive(N=31)
Aldo
(N=5)
I PRA t I(N= 13) I
PRA
+
Aldot(N10)
i
150 r
< 1Oo- iii0L
300
at 200[ i00L
150
1000
n- 50I
0
Fig. 2. Postural plasma renin and aldosterone responses in nor-
mal and diabetic subjects (mean SEM). Abbreviations used are:
PRA, plasma renin activity; PALDO, plasma aldosterone level; BP,
blood pressure; Pc0RT, plasma cortisol level.
Relationship between blood pressure and various
parameters. Supine mean blood pressure was 93 7
mm Hg in the normal subjects, 96 8 mm Hg in the
24 patients with a normal blood pressure, and 119
9 mm Hg in the 36 patients with hypertension. When
compared with the diabetic patients with a normal
0
at0
-I
—20
a
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Table 4. Comparison of various clinical and laboratory parameters between diabetic patients with normal postural renin or aldosterone
responses and non-responses
—
Renin Aldosterone
Responders Non-responders Responders Non-responders(N = 36) (N = 23) (N = 44) (N = 15)
Mean age, yr 55.0 12.0 55.1 13.7 56.0 12.3 52.3 13.7
Hypertension, % afflicted 58 61 59 66
Orthostatic blood pressure fall, %afflicted 11 17 16 7
Retinopathy, % afflicted 42 35 40 33
Neuropathy, % afflicted 33 35
Nephropathy, % afflicted 25 30 30 20
Insulin, % treated 50 43 50 53
Oral antidiabetic agents, % treated 33 35 39 27
Blood glucose, mg/100 ml 213.6 94.9 188.1 99.6 210.2 95.2 193.4 113.4
Exchangeable sodium, mEq/kg 0fLBM 48.0 4.3 49.9 5.1 48.7 5.1 48.2 3.1
Blood volume, mi/kg ofLBM 69.3 11.5 75.6 7.8 71.5 11.2 72.1 8.9
Urinary sodium excretion, mEqi24 hr 147.7 62.2 159.7 69.2 146.0 66.2 171.3 57.6
Plasma sodium, mEqiliter 137.5 3.0 137.4 2.4 137.3 2.9 137.5 2.4
Plasma potassium, ,nEqiiiter 3.98 0.35 4.05 0.37 4.03 0.34 3.99 0.28
Urinary adrenaline, p-gig of creatinine 2.2 3.3 3.8 3.4 2.8 3.4 3.0 3.5
Urinary noradrenaline, p-gig of creatinine 27.3 18.3 28.8 15.9 27.6 17.5 29.4 16.8
Urinary total catecholamines, p-gig of
creatinine 29.4 18.7 32.6 17.1 30.4 17.6 32.3 18.6
blood pressure, those with hypertension had a great-
er mean orthostatic decrease in mean blood pressure
(18.3 vs. 3.8 mm Hg; P <0.01), and they tended to
have a slightly lower mean upright PRA (2.46 1.72
vs. 3.76 2.55 ng/mI/hr; P <0.05). Mean age, heart
rate, supine PRA, supine and upright plasma aldoste-
rone levels, plasma potassium and sodium concen-
trations, exchangeable sodium and blood volume,
the products of the natural logarithm of PRA and
exchangeable sodium or blood volume [13, 15], and
urinary sodium or catecholamine excretion rates did
not differ significantly among these groups.
Linear regression analysis of supine mean blood
pressure on the various measured parameters was
performed. In normal subjects, blood pressure corre-
lated positively, although weakly, with noradrenaline
excretion rate (r = 0.40; P <0.02), but not with any
of the other parameters. In the diabetic patients,
blood pressure correlated inversely, but also weakly,
with basal PRA (r =
—0.29; P <0.05) but not with
postural renin responses or any other study
parameter.
Comparison between diabetic patients without and
those with orthostatic hypotension revealed that the
latter group tended to have higher exchangeable
body sodium concentrations and lower supine and
upright PRA levels (P < 0.05); mean age, supine
heart rate, plasma aldosterone level, blood volume,
and urinary sodium excretion did not differ signifi-
cantly among these groups (Table 5). In addition, the
patients without orthostatic hypotension showed a
significant postural increase in pulse rate (P <
0.025), while those with orthostatic hypotension did
not. The patients with orthostatic hypotension also
tended to excrete less noradrenaline than the normal
subjects did (P <0.05).
Linear regression analysis in the diabetic patients
revealed significant correlations between orthostatic
changes in blood pressure and noradrenaline (r =
0.29; P < 0.05) or total catecholarnine excretion
rates (r = 0.35; P <0.01) or basal PRA (r = 0.54; P
<0.001) (Fig. 3), but not between postural variations
in blood pressure and the associated changes in PRA
(r = 0.06).
Discussion
This comparative analysis of various vasoactive
factors in 60 patients with stable non-azotemic diabe-
tes mellitus and age-matched normal subjects dem-
onstrated several abnormalities in the diabetic popu-
lation. These included a significant increase in the
concentration of exchangeable body sodium (P <
0.01), an impaired postural responsiveness of plasma
renin and/or aldosterone levels in 47% of the
patients, and a tendency for low basal PRA values
and urinary noradrenaline excretion rates (P <0.05)
in those patients who had orthostatic hypotension.
The finding of a 9.5% increase in the mean concen-
tration of exchangeable sodium in our diabetic study
population probably represents a real abnormality in
body composition and is not related to differences in
age or body habitus [13, 16, 17]. Several factors may
cause sodium retention in patients with diabetes mel-
litus. Since none of our patients had renal or heart
failure, edema, or increased plasma aldosterone lev-
els, the excess concentration of body sodium could
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Table 5. Comparison of findings in normal subjects and patients with or without orthostatic hypotensiona
Normal
subjects
Patients with diabetes mellitus
No orthostatic BP . Orthostatic BP J,(N = 35) (N = 51) (N = 9)
Age, yr 50.4 14.8 54.4 12.8 55.3 15.4
Mean blood pressure, mm Hg
supine 93.3 6.8 109.1 13.9° 114.9 16.0°
upright 90.9 6.7 102.5 10.7° 68.7 19.2°
Heart rate, beats/mm
supine 68.3 8.2 79.6 14.4° 80.3 18.5°
upright 91.1 17.1 98.7 15.20 92.9 12.8
Plasma renin activity, nglmi/hr
supine 1.51 l.t 1.85 1.27 1.03
upright 4.06 3.55 3.25 2.27 1.72 140c,d
Plasma aldosterone, ng/JOO ml
supine 5.2 3.3 5.4 3.4 4.38 2.8
upright 17.9 11.4 13.7 9.10 15.2 13.5
Exchangeable sodium, mEq/kg of
LBM 44.6 3.7 48.0 3.60 52.7 74e.d
Blood volume, mi/kg of LBM 73.5 10.0 70.9 9.7 74.8 14.2
Urinary adrenaline, sg/g ofcreatinine 3.5 4.4 3.0 3.5 1.4 1.5
Urinary noradrenaline, /.4gIg of
creatinine 30.3 14.2 29.2 17.8 19.7 lO.4c
Urinary sodium, mEq/24 hr 131.9 60.5 157.2 65.2 119.9 51.5
a All values represent the mean SD.
BP J. represents orthostatic decrease of blood pressure exceeding 40 mm Hg systolic and 20 mm Hg diastolic, andlor 27 mm Hg mean
pressure.
P < 0.05 vs. normal subjects.
P <0.05 vs. patients without postural hypotension.
Fig. 3. Relationships between orthostatic changes in blood pressure and noradrenaline
excretion rate or basal plasma renin activity in patients with diabetes mellitus.
not be explained by one of these mechanisms [15, 25,
26]. Insulin given acutely to patients with poorly
controlled diabetes is known to contribute to sodium
retention [27]. Exchangeable sodium, however, was
comparable in the 47% of our patients who chroni-
cally received insulin and in the 53% who did not
(48.4 3.5 vs. 50.0 5.5 mEq/kg of LBM). Yet
another factor which may influence the body sodium-
fluid state is the serum protein concentration. Our
diabetic patients had a lower concentration of serum
albumin than that of the normal subjects (4.19 0.37
[SD] vs. 4.35 0.33 g/100 ml; P <0.02), as has been
reported by others [28]. Thus, it is conceivable that a
reduction in plasma oncotic pressure could initially
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lead to a shift of fluid from the intravascular to the
extravascular space; the deficit in circulatory volume
would, in turn, result in a finite degree of renal
sodium retention, thus establishing a new steady-
state with increased extracellular sodium and fluid
volume and normal blood volume.
In previous studies of the renin-angiotensin system
in diabetes mellitus, basal plasma renin levels and/or
renin responsiveness to stimuli were described as
being normal in uncomplicated diabetes mellitus [1,
7] or in diabetes complicated by retinopathy [29],
while low values were reported in alloxan-diabetic
rats [1], diabetic patients with nephropathy [1, 6],
orthostatic hypotension [6] or hypertension [8], or
unselected diabetics [30]. Since the activity of the
renin-angiotensin-aldosterone system is normally
age-dependent [16, 23], evaluation of this factor was
included in the present study. Age-related decreases
in supine and upright PRA levels were noted in both
normal and diabetic subjects, while plasma aldoste-
rone levels showed a similar tendency in normal
subjects but not in patients with diabetes mellitus.
Moreover, taking the age of the patients into
account, we have found that basal plasma renin and
aldosterone levels were comparable in the diabetic
and normal subjects.
In contrast, the mean orthostatic rise in PRA was
significantly lowered in the diabetic patients (88 vs.
165%; P < 0.001), and the individual postural
increases in level of PRA and plasma aldosterone
were subnormal in 39 and 25% of patients, respec-
tively. Moreover, based on their plasma renin and
aldosterone responses, the diabetic population could
be stratified into four subgroups. Fifty-three percent
showed normal renin and aldosterone responses, 8%
had a normal renin response and a subnormal aldo-
sterone response, 22% had an impaired renin
response and a normal aldosterone response, and
17% exhibited subnormal responses of both renin
and aldosterone.
The diminished PRA responsiveness in some of
our patients did not occur preferentially in patients
with diabetic complications such as retinopathy,
nephropathy manifested by impaired glomerular fil-
tration rate or proteinuria, or orthostatic hypoten-
sion, as reported by others [1, 6, 29]. This distur-
bance in renin metabolism was also not related to
several factors known to inhibit renin release, includ-
ing aging [16, 23], overhydration [9, 23], hyperkale-
mia [31], or hypertension [12, 13, 23]. The dimin-
ished postural PRA responses, however, could
reflect certain other abnormalities known to be asso-
ciated with diabetes mellitus, such as impaired adre-
nergic activity [3, 10, 32-34] or hyalinosis of the
glomerular arterioles with destruction of the juxta-
glomerular apparatus [14, 35]. The finding of compa-
rable 24-hr catecholamine excretion rates in our
patients with normal or impaired renin-responsive-
ness does not exclude a role of the former factor,
since orthostatic changes in plasma catecholamines
were not assessed. On the other hand, afferent arter-
iolar sclerosis is an early event which may precede
the clinical signs of diabetic nephropathy [36]. Thus,
hyalinization of renin-producing cells or receptor
sites may well have contributed to diminished renin
responsiveness in our diabetic patients, regardless of
the presence or absence of impaired renal function or
proteinuria.
Postural dissociation of plasma renin and aldoste-
rone levels was noted in 30% of our diabetic patients.
The failure of plasma aldosterone levels to increase
with upright posture, despite a normal rise in PRA in
some patients, could be related either to an adrenal
biosynthetic abnormality or an ineffective form of
circulating renin. Based on the lack of clinical signs
of adrenal dysfunction, the normal basal plasma
aldosterone, cortisol and electrolyte levels, there
was no evidence for adrenocortical insufficiency. A
relatively inactive precursor of renin, termed "big
renin," however, has recently been identified in plas-
ma and kidney extracts of some patients with dia-
betic nephropathy [37]. Moreover, in two such
patients "big renin" replaced 50 to 100% of normal
circulating renin, and this was associated with aldo-
sterone deficiency [40].
The normal postural plasma aldosterone
responses, despite blunted or absent renin respon-
siveness in another sizeable subgroup of our diabetic
patients, could not be explained by several known
aldosterone-regulating mechanisms such as varia-
tions in concentrations of plasma potassium or
sodium,. or the level of ACTH as judged by plasma
cortisol concentrations. Since angiotensin levels and
adrenal sensitivity to angiotensin were not actually
measured, the renin-angiotensin system cannot be
dismissed with certainty as a regulator of aldosterone
release in these patients. The finding of marked pos-
tural falls in blood pressure in our diabetic patients,
as well as in anephric subjects [39] or patients with
dysautonomia [40] in whom similarly unexplained
orthostatic aldosterone stimulation occurred, how-
ever, suggests that a decrease in systemic pressure
may be an additional stimulus, triggering an aldoste-
rone-secretory response via mediators other than
renin, potassium, sodium, or ACTH.
When evaluated in the supine position, 60% of our
diabetic patients had hypertension. In this study pop-
ulation, no positive correlations were observed
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among blood pressure and major blood pressure-
regulating factors, such as PRA, circulatory volume,
concentration of exchangeable sodium, or catechol-
amine excretion rates, singly or in combination. Oth-
ers found also no relationship between blood pres-
sure and circulating total catecholamines [3].
Furthermore, the normal or even low activity of the
sympathetic and renin-angiotensin systems suggests
that they are probably not of primary importance in
the maintenance of hypertension associated with dia-
betes mellitus. On the other hand, it appears possible
that the increased concentration of body sodium may
have contributed to the hypertension in our patients.
The lack of a significant blood pressure-sodium rela-
tionship is not against this, but could reflect marked
variability in the vascular sensitivity to sodium andl
or an important complementary role of other factors
not delineated in this study [15, 26].
Nine (15%) of our diabetic patients had marked
orthostatic hypotension. The mechanisms control-
ling postural blood pressure homeostasis are very
complex, including neural, hemodynamic, fluid-elec-
trolyte, and, possibly, circulating pressor factors,
such as catecholamines and angiotensin II [41].
Body fluid volume depletion did not appear to con-
tribute to the orthostatic hypotension in our patients,
since their blood volumes were normal, and their
mean concentration of exchangeable sodium tended
to be even higher than that in the patients with
normal postural blood pressure regulation (P <
0.05). Orthostatic hypotension in diabetic patients is
usually associated with impaired function of the
afferent (parasympathetic) and/or efferent (sympa-
thetic) limb of the autonomic reflex arch [2, 42, 43],
and low serum activities of dopamine beta-hydroxyl-
ase were reported [33]. The previous observation of
an association among postural decreases in blood
pressure and impaired responsiveness of PRA to
upright posture [61 was not confirmed in the present
study, although the lack of an exaggerated orthostat-
ic renin-response in our patients with orthostatic
hypotension may be considered inappropriate [44].
In this diabetic study population, postural changes in
blood pressure correlated directly with basal PRA (r
= 0.54; P < 0.001) and total catechlolamine excre-
tion rate (r = 0.35; P < 0.05), and patients with
orthostatic hypotension tended to have decreases in
both circulating renin and noradrenaline excretion (P
< 0.05). A retrospective analysis of another study
indicates that the 12 anephric patients who had no
functioning renin-angiotensin system were more
prone to orthostatic decreases in blood pressure than
the 17 non-nephrectomized hemodialysis patients
with normal to high PRA (14.3 3.9 [sUM] vs. 1.2
2.8%; P <0.01) [39, 45]. The latter data support the
conclusion that low activity of the renin-angiotensin
system may be a factor complementing autonomic
insufficiency in the pathogenesis of diabetic ortho-
static hypotension.
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